A study that tested the hypothesis that polycystic ovary syndrome (PCOS) is linked with autism may inform new interventions for PCOS and autism. PLUS: Does smoking exposure deter breastfeeding? ALSO: Does race play a role in maternal outcomes for older women?
Judith M. Orvos, ELS
Internet addiction often is linked with depression but a new study suggests that there is a way to use the technology to help encourage teens with postpartum depression to get treatment.
A national poll suggests that most adults with children favor some type of state support for pregnant teens. But how strongly someone feels about that and whether the help comes with caveats may be influenced by the person’s gender.
Findings from a recent study illustrate why you should be talking with your pregnant patients about their consumption of fatty acids.
Release of results from the ARRIVE trial has provided answers to some concerns about 39-week induction while leading to some questions about the participants and the implication of the findings for clinical practice. PLUS: CDC updates on Zika virus. Also: FDA warns about tests for rupture of membranes
To fight the opioid epidemic, ob/gyns, like all physicians, are looking for ways to help prevent substance use disorders and enhanced recovery programs (ERAS) could play a role. PLUS: Are EDs screening adolescents with PID for HIV, syphilis? ALSO: Results of a new retrospective study show that a woman’s race may impact how likely she is to have a myomectomy—and alarmingly, whether the procedure is likely to result in morbidity.
Incidence of acute myocardial infarction (AMI) continues to increase in women during pregnancy and the puerperium. Data from a new study point to underlying factors contributing to that trend. PLUS: Results of a large population-based study of POP procedures provide new insights into what factors other than the material may play a role in the adverse surgical outcomes.
Ob/gyns and other women’s health providers can help save Title X for their patients and their voices need to be heard on Capitol Hill. That was the clear message from speakers at a recent media event in Washington, DC.
The manufacturer of a device for permanent birth control that reportedly causes serious adverse events has decided to cease selling it at the end of the year. PLUS: Does smoking cessation really = weight gain? Also: Is prenatal depression more common today?
Research point to risk as well as benefits of extended adjuvant tamoxifen for ER-positive BCa. PLUS: Should breast cancer screening be risk-based? ALSO: Side effects of cross-sex hormones in transwomen.